| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |